)
Calix (CXL) investor relations material
Calix H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved strong revenue and gross profit growth in 1H FY26, with magnesia revenue up 48% year-over-year and group product & services revenue up 21% compared to 1H FY25, driven by the magnesia business and initial contributions from sustainable processing.
Operating expenses reduced by 30% year-over-year, with disciplined cost management, streamlined operations, and a capital-light business model.
Significant commercial milestones reached, including a major U.S. magnesia contract, Rio Tinto partnership, and completion of the lithium Mid-Stream Demonstration Plant.
A $30.2m non-cash impairment was recorded due to the planned sale of the Midstream project stake, resulting in a net loss of $42.8m for the period.
Net cash used in operating activities decreased to $6.2m, and cash and equivalents were $11.8m at 31 December 2025.
Financial highlights
Product and services revenue reached AUD 16.3 million (up 21% year-over-year); magnesia revenue AUD 15.8 million (up 48%).
Gross profit increased 37% to AUD 6.7 million, with gross margin rising to 40% from 37% year-over-year.
Operating expenditure down 30% to AUD 15.6 million; net cash used in operating activities down 65% to AUD 6.2 million.
CapEx spend reduced to AUD 600,000 (excluding Mid-Stream Project share); total CapEx $7.1m, focused on Magnesia and Midstream projects.
Net loss for the period was $42.8m, driven by a $30.2m impairment related to the Midstream project sale.
Outlook and guidance
Expecting cash flow neutrality in calendar year 2026, driven by continued revenue and gross profit growth, reduced OpEx, and minimal CapEx, excluding anticipated $11.4m cash payment from PLS.
Anticipate additional cash inflows from government grants, project milestones, R&D tax incentives, and the sale of the Midstream project stake.
Major new magnesia contract to begin contributing in the second half, with ramp-up expected over several months.
Focus on progressing ZESTY to final investment decision and advancing key projects in alumina and lime.
Directors consider the group a going concern based on current forecasts and cost controls.
- Revenue up 30% and gross margin at 43% as key projects and new grants drive growth.CXL
H2 202412 Feb 2026 - Revenue up 11% to $13.5m; cost savings, grants, and projects extend cash runway and outlook.CXL
H1 202512 Feb 2026 - Revenue up 11% to $33.9m, costs down 23%, and cash runway extended to 18 months.CXL
H2 202512 Feb 2026 - ZESTY and Leilac advance scalable, low-emission solutions for steel and cement industries.CXL
Status Update1 Feb 2026 - Cost discipline, project focus, and strong shareholder support drive future growth.CXL
AGM 202412 Jan 2026 - Strong revenue growth and major decarbonisation projects drive robust shareholder support.CXL
AGM 202518 Nov 2025 - $44.9M ARENA grant advances flexible, low-emission ironmaking tech toward 2028 launch.CXL
Status Update16 Nov 2025 - Energy-flexible kiln tech drives 11% revenue growth and global awards as key projects advance.CXL
Status Update12 Nov 2025 - Award-winning technology drives decarbonisation and electrification across global industries.CXL
Investor Presentation20 Oct 2025
Next Calix earnings date
Next Calix earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)